Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.246 HKD | +0.41% | +13.36% | +82.22% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 251.6 | 224.5 | 1,509 | 801.1 | 178.8 | 61.48 |
Enterprise Value (EV) 1 | 26.17 | 77.25 | 1,477 | 801.5 | 130.5 | 0.6066 |
P/E ratio | -0.11 x | -0.27 x | -131 x | 518 x | -198 x | 90 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.4 x | 1.55 x | 19 x | 9.78 x | 1.78 x | 1.03 x |
EV / Revenue | 0.15 x | 0.53 x | 18.6 x | 9.79 x | 1.3 x | 0.01 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | 0.16 x | 0.24 x | 3.52 x | 1.81 x | 0.45 x | 0.15 x |
Nbr of stocks (in thousands) | 387,010 | 387,010 | 387,010 | 387,010 | 425,711 | 455,441 |
Reference price 2 | 0.6500 | 0.5800 | 3.900 | 2.070 | 0.4200 | 0.1350 |
Announcement Date | 4/26/19 | 5/14/20 | 4/29/21 | 6/28/22 | 4/28/23 | 4/26/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 180 | 145.3 | 79.6 | 81.89 | 100.3 | 59.78 |
EBITDA | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -2,179 | -812.4 | -9.172 | 6.96 | 9.323 | 4.745 |
Net income 1 | -2,199 | -825.7 | -11.49 | 6.055 | -0.904 | 2.313 |
Net margin | -1,221.39% | -568.39% | -14.43% | 7.39% | -0.9% | 3.87% |
EPS 2 | -5.682 | -2.133 | -0.0297 | 0.004000 | -0.002123 | 0.001500 |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/26/19 | 5/14/20 | 4/29/21 | 6/28/22 | 4/28/23 | 4/26/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 0.42 | - | - |
Net Cash position 1 | 225 | 147 | 32.1 | - | 48.3 | 60.9 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | -76.4% | -65.2% | -1.5% | 1.34% | 0.16% | 0.59% |
ROA (Net income/ Total Assets) | -73.1% | -56.3% | -1.25% | 1.25% | 0.14% | 0.51% |
Assets 1 | 3,010 | 1,468 | 916.5 | 486.2 | -646.6 | 455.8 |
Book Value Per Share 2 | 3.980 | 2.440 | 1.110 | 1.150 | 0.9300 | 0.8900 |
Cash Flow per Share 2 | 0.4600 | 0.4000 | 0.1100 | 0.0500 | 0.1400 | 0.1800 |
Capex 1 | 29.4 | - | 1.35 | 0.89 | 1.03 | - |
Capex / Sales | 16.34% | - | 1.7% | 1.09% | 1.03% | - |
Announcement Date | 4/26/19 | 5/14/20 | 4/29/21 | 6/28/22 | 4/28/23 | 4/26/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+82.22% | 14.01M | |
-7.96% | 50.03B | |
-6.04% | 30.54B | |
+53.53% | 27.29B | |
+26.39% | 24.77B | |
+14.01% | 17.99B | |
+1.25% | 13.03B | |
+15.00% | 10.71B | |
+15.70% | 8.21B | |
-29.45% | 7.49B |
- Stock Market
- Equities
- 767 Stock
- Financials Zhong Ji Longevity Science Group Limited